115 related articles for article (PubMed ID: 7932553)
1. 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.
Stjernlöf P; Elebring T; Nilsson J; Andersson B; Lagerkvist S; Svensson K; Ekman A; Carlsson A; Wikström H
J Med Chem; 1994 Sep; 37(20):3263-73. PubMed ID: 7932553
[TBL] [Abstract][Full Text] [Related]
2. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
J Med Chem; 1993 Jul; 36(15):2059-65. PubMed ID: 8340910
[TBL] [Abstract][Full Text] [Related]
3. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
[TBL] [Abstract][Full Text] [Related]
4. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants.
Romero AG; Leiby JA; McCall RB; Piercey MF; Smith MW; Han F
J Med Chem; 1993 Jul; 36(15):2066-74. PubMed ID: 8101876
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability.
Lin CH; Haadsma-Svensson SR; Phillips G; McCall RB; Piercey MF; Smith MW; Svensson K; Carlsson A; Chidester CG; Von Voigtlander PF
J Med Chem; 1993 Jul; 36(15):2208-18. PubMed ID: 8340922
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 1. Effects of substituents in the aromatic system on serotonin and dopamine receptor subtypes.
Stjernlöf P; Ennis MD; Hansson LO; Hoffman RL; Ghazal NB; Sundell S; Smith MW; Svensson K; Carlsson A; Wikström H
J Med Chem; 1995 Jun; 38(12):2202-16. PubMed ID: 7783152
[TBL] [Abstract][Full Text] [Related]
8. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H
J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.
Ennis MD; Stjernlöf P; Hoffman RL; Ghazal NB; Smith MW; Svensson K; Wikström H; Haadsma-Svensson SR; Lin CH
J Med Chem; 1995 Jun; 38(12):2217-30. PubMed ID: 7783153
[TBL] [Abstract][Full Text] [Related]
10. C-9 and N-substituted analogs of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3- propyl-1H-benz[e]indole-9-carboxamide: 5-HT1A receptor agonists with various degrees of metabolic stability.
Haadsma-Svensson SR; Svensson K; Duncan N; Smith MW; Lin CH
J Med Chem; 1995 Feb; 38(4):725-34. PubMed ID: 7861420
[TBL] [Abstract][Full Text] [Related]
11. 6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists.
Wikström H; Andersson B; Elebring T; Lagerkvist S; Hallnemo G; Pettersson I; Jovall PA; Svensson K; Ekman A; Carlsson A
J Med Chem; 1992 Oct; 35(22):3984-90. PubMed ID: 1433207
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
Mattsson C; Svensson P; Boettcher H; Sonesson C
Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
[TBL] [Abstract][Full Text] [Related]
13. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
[TBL] [Abstract][Full Text] [Related]
14. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.
Liu Y; Yu H; Mohell N; Nordvall G; Lewander T; Hacksell U
J Med Chem; 1995 Jan; 38(1):150-60. PubMed ID: 7530773
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists.
Isaac M; Slassi M; Xin T; Arora J; O'Brien A; Edwards L; MacLean N; Wilson J; Demschyshyn L; Labrie P; Naismith A; Maddaford S; Papac D; Harrison S; Wang H; Draper S; Tehim A
Bioorg Med Chem Lett; 2003 Dec; 13(24):4409-13. PubMed ID: 14643336
[TBL] [Abstract][Full Text] [Related]
16. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents.
Mokrosz MJ; Mokrosz JL; Duszyńska B; Dereń-Wesołek A; Kłodzińska A; Kowalski P; Charakchieva-Minol S; Tatarczyńska E; Kowalska T; Majka Z; Chojnacka-Wójcik E; Misztal S
Pharmazie; 1997 Jun; 52(6):423-8. PubMed ID: 9260266
[TBL] [Abstract][Full Text] [Related]
17. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
McCall RB; Romero AG; Bienkowski MJ; Harris DW; McGuire JC; Piercey MF; Shuck ME; Smith MW; Svensson KA; Schreur PJ
J Pharmacol Exp Ther; 1994 Nov; 271(2):875-83. PubMed ID: 7965808
[TBL] [Abstract][Full Text] [Related]
18. Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors.
Liu Y; Yu H; Svensson BE; Cortizo L; Lewander T; Hacksell U
J Med Chem; 1993 Dec; 36(26):4221-9. PubMed ID: 7506312
[TBL] [Abstract][Full Text] [Related]
19. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
20. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
